Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Sets March Date for Shareholder Meeting

Premium

Vermillion said this week that it will hold its 2012 shareholder meeting on March 21.

The scheduling of the meeting had become an issue for the company recently, with Vermillion last week receiving a notice from the Nasdaq Stock Market that it was not in compliance with the exchange's listing rule that companies hold an annual shareholder meeting no later than one year after the end of their fiscal year.

Also last week, Vermillion shareholder George Bessenyei brought an action against the company in the Delaware Court of Chancery to force it to hold its annual meeting (PM 1/11/2013).

At the meeting, one board seat will be up for election. The company has nominated Roberta Della Vedova for election to the seat. Vedova is the vice president of human resources and head of global diagnostic sales at biotech firm eBiosciences. She was also a co-founder of tumor testing firm AlliedPath.

Bessenyei and his fellow shareholders Gregory Novak and Robert Goggin have filed documents indicating they plan to nominate Goggin for the open seat. Goggin is a lawyer and an owner and director of Philadelphia-based law firm Keller & Goggin.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.